An algorithm for the clinical and pathomorphological study of endometrial carcinoma;Algorithmus der klinik und pathologie des endometriumkarzinoms

Pathologe

Volumn 20, Issue 1, 1999, Pages 63-71

  Loning Th ^a   Reusch, Ursula ^a   Thomssen, Ch ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Diagnosis; Endometrial cancer; Incidence; Prognostic factors; Treatment

Indexed keywords

ANTHRACYCLINE; ANTIINFECTIVE AGENT; ESTROGEN; MEDROXYPROGESTERONE ACETATE; TAMOXIFEN;

ARTICLE; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CANCER; ESTROGEN THERAPY; FEMALE; HORMONAL CARCINOGENESIS; HORMONAL THERAPY; HUMAN; METASTASIS; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; TRANSVAGINAL ECHOGRAPHY; TREATMENT INDICATION;

ALGORITHMS; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, HORMONE-DEPENDENT; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0344923771     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002920050321     Document Type: Article

References (45)

1. Ambros RA, Kurman RJ (1992a) Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol 45:235-239
2. Ambros RA, Kurman RJ (1992b) Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 69:1424-1431
3. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland (1997) Krebs in Deutschland - Häufigkeiten und Trends. Bundesministerium für Gesundheit, Bonn-Saarbrücken
4. Berchuck A, Evans AC, Boyd J (1997) Alterations of oncogenes and tumor-suppressor genes in endometrial cancer. In: Langdon SP, Miller WR, Berchuck A (eds) Biology of female cancers. CRC Press, Boca Raton New York, pp 205-217
5. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17
6. Boronow RC (1990) Advances in diagnosis, staging, and management of cervical and endometrial cancer, stages I and II. Cancer 65:648-659
7. Boronow RC (1997) Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge - a personal perspective. Gynecol Oncol 66:179-189
8. Brinton LA, Hoover RN (1992) Epidemiology of gynecologic cancers. In: Hoskins WJ, Perez CA, Young RC (eds) Principles and practice of gynecologic oncology. Lippincott, Philadelphia, pp 3-26
9. Britton LC, Wilson TO, Gaffey TA, Cha SS, Wieand HS, Podratz KC (1990) DNA ploidy in endometrial carcinoma: major objective prognostic factor. Mayo Clin Proc 65:643-650
10. Choo YC, Naylor B (1982) Multiple primary neoplasms of the ovary and uterus. Int J Gynaecol Obstet 20:327-334
11. Creasman WT (1997) Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. Semin Oncol 24:S1-140-S1-50
12. Deligdisch L, Holinka CF (1987) Endometrial carcinoma: two diseases? Cancer Detect Prev 10:237-246
13. DelMaschio A, Vanzulli A, Sironi S, Spagnolo D, Belloni C, Garancini P, Taccagni GL (1993) Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. Am J Roentgenol 160:533-538
14. Demopoulos RI, Dubin N, Noumoff J, Blaustein A, Sommers GM (1986) Prognostic significance of squamous differentiation in stage I endometrial adenocarcinoma. Obstet Gynecol 68:245-250
15. Eifel P, Hendrickson M, Ross J, Ballon S, Martinez A, Kempson R (1982) Simultaneous presentation of carcinoma involving the ovary and the uterine corpus. Cancer 50:163-170
16. Fujita M, Shroyer KR, Markham NE, Inoue M, Iwamoto S, Kyo S, Enomoto T (1995) Association of human papillomavirus with malignant and premalignant lesions of the uterine endometrium. Hum Pathol 26:650-658
17. Hendrickson MR, Kempson RL (1991) The uterine corpus. In: Sternberg SS, Mills SE (eds) Surgical pathology of the reproductive system and peritoneum. Raven, New York, pp 105-168
18. Kadar NR, Kohorn EI, LiVolsi VA, Kapp DS (1982) Histologic variants of cervical involvement by endometrial carcinoma. Obstet Gynecol 59:85-92
19. Kimmig R, Hasbargen U, Hepp H (1993) Hysteroscopic staging of endometrial cancer. Comment on the contribution by R. Schild, Th. Kutter (letter; comment). Geburtshilfe Frauenheilkd 53:433-434
20. Kurman RJ, Morris HJ (1994) Endometrial carcinoma. In: Kurman RJ (ed) Blaustein's pathology of the female genital tract. Springer, Berlin Heidelberg New York
21. Lampe B, Kurzl R, Dimpfl T, Fawzi H (1997) Accuracy of preoperative histology and macroscopic assessment of cervical involvement in endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol 74:205-209
22. Lax SF, Kurman RJ (1997) A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol 81:228-232
23. Lindahl B, Ranstam J, Willen R (1994) Five year survival rate in endometrial carcinoma stages I-II: influence of degree of tumour differentiation, age, myometrial invasion and DNA content. Br J Obstet Gynaecol 101:621-625
24. Lindahl B, Ranstam J, Norgren A, Willen R (1995) Identification of high-risk groups in endometrial carcinoma stage I-II. A combination of DNA- and steroid receptor-measurements identifies early deaths from the disease. Anticancer Res 15:1095-1100
25. Löning T, Schlechte H, Friedrichs K, Schnoor D, Ditscherlein G, Bommer G, Löning S (1993) p53 in urogenital tumors:analysis of expression and mutation. Verh Dtsch Ges Pathol 77:117-118
26. Massi G, Savino L, Susini T (1996a) Vaginal hysterectomy versus abdominal hysterectomy for the treatment of stage I endometrial adenocarcinoma. Am J Obstet Gynecol 174:1320-1326
27. Massi G, Savino L, Susini T (1996b) Three classes of radical vaginal hysterectomy for treatment of endometrial and cervical cancer. Am J Obstet Gynecol 175:1576-1585
28. Milde-Langosch K, Becker G, Löning T (1991a) Human papillomavirus and c-myc/c-erbB2 in uterine and vulvar lesions. Virchows Arch [A] 419:479-485
29. Milde-Langosch K, Wilckens C, Brack T, Löning T (1991b) Demonstration and biological significance of viral and cellular oncogenes in uterine carcinomas. Verh Dtsch Ges Pathol 75:363-365
30. Mittal KR, Schwartz PE, Barwick KW (1988) Architectural (FIGO) grading, nuclear grading, and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high-risk and low-risk groups. Cancer 61:538-545
31. Nordstrom B, Strang P, Bergstrom R, Nilsson S, Tribukait B (1996) A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction. Cancer 78:1942-1951
32. Park RC, Grigsby PW, Muss HB, et al (1992) Corpus: epithelial tumors. In: Moskins WJ, Perez CA, Young RC (eds) Principles and practice of gynecologic oncology. Lippincott, Philadelphia, pp 663-693
33. Philippe E, Charpin C (1992) Pathologie gynecologique et obstetricale. Masson, Paris
34. Podratz KC, Wilson TO, Gaffey TA, Cha SS, Katzmann JA (1993) Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients. Am J Obstet Gynecol 168:1206-1213
35. Prat J, Oliva E, Lerma E, Vaquera M, Matias Guiu X (1994) Uterine papillary serous adenocarcinoma. A10-case study of p53 and c-erbB-2 expression and DNA content. Cancer 74:1778-1783
36. Riethdorf L, Begemann C, Riethdorf S, Milde-Langosch K, Löning T (1996) Benign and malignant endometrial lesions compared for their p53 state by immunohistochemistry and temperature-gradient gel electrophoresis. Virchows Arch 428:47-51
37. Schulz KD, Emons G (1995) Endometriumkarzinom. In: Zeller HJ, zur Hausen H (eds)Onkologie. Grundlagen - Diagnostik - Therapie - Entwicklungen. ecomed, Landsberg
38. Scully RE, Bonfiglio TA, Kurman RJ et al (1994) Histological typing of female genital tract tumors. Springer, Berlin Heidelberg New York
39. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ (1992) Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16:600-610
40. Stegner HE (1994) Pathologie der weiblichen Genitalorgane. II.Pathologie der Ovarien und Eileiter. Springer, Berlin Heidelberg New York
41. Tashiro H, Lax SF, Gaudin PB, Isacson C, Cho KR, Hedrick L (1997) Microsatellite instability is uncommon in uterine serous carcinoma. Am J Pathol 150:75-79
42. Ulbright TM, Roth LM (1985) Metastaticand independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 16:28-34
43. Vergote IB (1994) Adjuvant postoperative treatment of endometrial cancer. Gynakologe 27:84-88
44. Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R, Advani H (1991) The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. Cancer 68:2293-2302
45. Zaino RJ, Silverberg SG, Morris HJ, Bundy BN, Morrow CP, Okagaki T (1994) The prognostic value of nuclear versus architectural grading in endometrial adenocarcinoma: a Gynecologic Oncology Group study. Int J Gynecol Pathol 13:29-36